Japan Biosimilars Market Report 2016

November 2016 | 122 pages | ID: JEFCF23F375EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Biosimilars

Revenue, means the sales value of Biosimilars

This report studies sales (consumption) of Biosimilars in Japan market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Roche
• Amgen
• AbbVie
• Sanofi-Aventis
• Johnson & Johnson
• Pfizer
• Novo Nordisk
• Eli Lilly
• Novartis
• Merck
• 3sbio
• Changchun High Tech
• CP Guojian
• Biotech
• Gelgen
• Innovent

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Antibody
• Hormone
• Growth Factors
• Others

Split by applications, this report focuses on sales, market share and growth rate of Biosimilars in each application, can be divided into

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Others

Contents

Japan Biosimilars Market Report 2016

1 BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of Biosimilars
1.2 Classification of Biosimilars
  1.2.1 Antibody
  1.2.2 Hormone
  1.2.3 Growth Factors
  1.2.4 Others
1.3 Application of Biosimilars
  1.3.1 Tumor
  1.3.2 Diabetes
  1.3.3 Cardiovascular
  1.3.4 Hemophilia
  1.3.5 Others
1.4 Japan Market Size Sales (Value) and Revenue (Volume) of Biosimilars (2011-2021)
  1.4.1 Japan Biosimilars Sales and Growth Rate (2011-2021)
  1.4.2 Japan Biosimilars Revenue and Growth Rate (2011-2021)

2 JAPAN BIOSIMILARS COMPETITION BY MANUFACTURERS

2.1 Japan Biosimilars Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Japan Biosimilars Revenue and Share by Manufactures (2015 and 2016)
2.3 Japan Biosimilars Average Price by Manufactures (2015 and 2016)
2.4 Biosimilars Market Competitive Situation and Trends
  2.4.1 Biosimilars Market Concentration Rate
  2.4.2 Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 JAPAN BIOSIMILARS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 Japan Biosimilars Sales and Market Share by Type (2011-2016)
3.2 Japan Biosimilars Revenue and Market Share by Type (2011-2016)
3.3 Japan Biosimilars Price by Type (2011-2016)
3.4 Japan Biosimilars Sales Growth Rate by Type (2011-2016)

4 JAPAN BIOSIMILARS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 Japan Biosimilars Sales and Market Share by Application (2011-2016)
4.2 Japan Biosimilars Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 JAPAN BIOSIMILARS MANUFACTURERS PROFILES/ANALYSIS

5.1 Roche
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Biosimilars Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Amgen
  5.2.2 Biosimilars Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 AbbVie
  5.3.2 Biosimilars Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Sanofi-Aventis
  5.4.2 Biosimilars Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Johnson & Johnson
  5.5.2 Biosimilars Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Pfizer
  5.6.2 Biosimilars Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Novo Nordisk
  5.7.2 Biosimilars Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Eli Lilly
  5.8.2 Biosimilars Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Novartis
  5.9.2 Biosimilars Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Merck
  5.10.2 Biosimilars Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 3sbio
5.12 Changchun High Tech
5.13 CP Guojian
5.14 Biotech
5.15 Gelgen
5.16 Innovent

6 BIOSIMILARS MANUFACTURING COST ANALYSIS

6.1 Biosimilars Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biosimilars

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Biosimilars Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biosimilars Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 JAPAN BIOSIMILARS MARKET FORECAST (2016-2021)

10.1 Japan Biosimilars Sales, Revenue Forecast (2016-2021)
10.2 Japan Biosimilars Sales Forecast by Type (2016-2021)
10.3 Japan Biosimilars Sales Forecast by Application (2016-2021)
10.4 Biosimilars Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biosimilars
Table Classification of Biosimilars
Figure Japan Sales Market Share of Biosimilars by Type in 2015
Figure Antibody Picture
Figure Hormone Picture
Figure Growth Factors Picture
Figure Others Picture
Table Application of Biosimilars
Figure Japan Sales Market Share of Biosimilars by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Others Examples
Figure Japan Biosimilars Sales and Growth Rate (2011-2021)
Figure Japan Biosimilars Revenue and Growth Rate (2011-2021)
Table Japan Biosimilars Sales of Key Manufacturers (2015 and 2016)
Table Japan Biosimilars Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biosimilars Sales Share by Manufacturers
Figure 2016 Biosimilars Sales Share by Manufacturers
Table Japan Biosimilars Revenue by Manufacturers (2015 and 2016)
Table Japan Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Japan Biosimilars Revenue Share by Manufacturers
Table 2016 Japan Biosimilars Revenue Share by Manufacturers
Table Japan Market Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure Japan Market Biosimilars Average Price of Key Manufacturers in 2015
Figure Biosimilars Market Share of Top 3 Manufacturers
Figure Biosimilars Market Share of Top 5 Manufacturers
Table Japan Biosimilars Sales by Type (2011-2016)
Table Japan Biosimilars Sales Share by Type (2011-2016)
Figure Japan Biosimilars Sales Market Share by Type in 2015
Table Japan Biosimilars Revenue and Market Share by Type (2011-2016)
Table Japan Biosimilars Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biosimilars by Type (2011-2016)
Table Japan Biosimilars Price by Type (2011-2016)
Figure Japan Biosimilars Sales Growth Rate by Type (2011-2016)
Table Japan Biosimilars Sales by Application (2011-2016)
Table Japan Biosimilars Sales Market Share by Application (2011-2016)
Figure Japan Biosimilars Sales Market Share by Application in 2015
Table Japan Biosimilars Sales Growth Rate by Application (2011-2016)
Figure Japan Biosimilars Sales Growth Rate by Application (2011-2016)
Table Roche Basic Information List
Table Roche Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Biosimilars Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biosimilars Sales Market Share (2011-2016)
Table AbbVie Basic Information List
Table AbbVie Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table AbbVie Biosimilars Sales Market Share (2011-2016)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi-Aventis Biosimilars Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biosimilars Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Biosimilars Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biosimilars Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Biosimilars Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biosimilars Sales Market Share (2011-2016)
Table Merck Basic Information List
Table Merck Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck Biosimilars Sales Market Share (2011-2016)
Table 3sbio Basic Information List
Table 3sbio Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table 3sbio Biosimilars Sales Market Share (2011-2016)
Table Changchun High Tech Basic Information List
Table Changchun High Tech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Changchun High Tech Biosimilars Sales Market Share (2011-2016)
Table CP Guojian Basic Information List
Table CP Guojian Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table CP Guojian Biosimilars Sales Market Share (2011-2016)
Table Biotech Basic Information List
Table Biotech Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biotech Biosimilars Sales Market Share (2011-2016)
Table Gelgen Basic Information List
Table Gelgen Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gelgen Biosimilars Sales Market Share (2011-2016)
Table Innovent Basic Information List
Table Innovent Biosimilars Sales, Revenue, Price and Gross Margin (2011-2016)
Table Innovent Biosimilars Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilars
Figure Manufacturing Process Analysis of Biosimilars
Figure Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biosimilars
Table Distributors/Traders List
Figure Japan Biosimilars Production and Growth Rate Forecast (2016-2021)
Figure Japan Biosimilars Revenue and Growth Rate Forecast (2016-2021)
Table Japan Biosimilars Production Forecast by Type (2016-2021)
Table Japan Biosimilars Consumption Forecast by Application (2016-2021)